Citation Impact
Citing Papers
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses
2020 Standout
Transcriptional regulation of macrophage polarization: enabling diversity with identity
2011 Standout
Recognition of herpesviruses by the innate immune system
2011
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
2012 Standout
Global virus outbreaks: Interferons as 1st responders
2019
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells
2010 StandoutNobel
Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4
2017 StandoutNobel
A compendium of proteins that interact with HIF-1α
2017 StandoutNobel
Type I interferons in infectious disease
2015 Standout
Regulation of immunity and oncogenesis by the IRF transcription factor family
2010
The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study
2011 Standout
Interferons: Signaling, antiviral and viral evasion
2008
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus
2009
KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi’s sarcoma
2015 StandoutNobel
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity
2009
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Regulation of type I interferon responses
2013 Standout
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA
2010 Standout
Interferon-stimulated genes and their antiviral effector functions
2011 StandoutNobel
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist
2014 StandoutNobel
Epstein-Barr Virus BGLF4 Kinase Suppresses the Interferon Regulatory Factor 3 Signaling Pathway
2008
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections
2014 StandoutNobel
Viral evasion and subversion of pattern-recognition receptor signalling
2008
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007 Standout
Dissociation of Paramyxovirus Interferon Evasion Activities: Universal and Virus-Specific Requirements for Conserved V Protein Amino Acids in MDA5 Interference
2010
The IRF Family Transcription Factors in Immunity and Oncogenesis
2008
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Kaposi's Sarcoma–Associated Herpesvirus Viral IFN Regulatory Factor 3 Stabilizes Hypoxia-Inducible Factor-1α to Induce Vascular Endothelial Growth Factor Expression
2008
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
2019 StandoutNobel
Herpes Virus Fusion and Entry: A Story with Many Characters
2012
Works of Liguo Wu being referenced
Inhibition of Interferon Regulatory Factor 7 (IRF7)-Mediated Interferon Signal Transduction by the Kaposi's Sarcoma-Associated Herpesvirus Viral IRF Homolog vIRF3
2007
Epstein-Barr Virus LF2: an Antagonist to Type I Interferon
2008
Mutations of Epstein-Barr Virus gH That Are Differentially Able To Support Fusion with B Cells or Epithelial Cells
2005